YUSPEH ALAN R 4
4 · HCA Healthcare, Inc. · Filed Feb 20, 2018
Insider Transaction Report
Form 4
YUSPEH ALAN R
SVP & Chief Ethics Officer
Transactions
- Tax Payment
Common Stock
2018-02-16$101.00/sh−6,497$656,197→ 28,534 total - Exercise/Conversion
Stock Appreciation Right
2018-02-16−5,500→ 0 totalExercise: $37.18Exp: 2023-02-06→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2018-02-16$37.18/sh+12,375$460,103→ 35,031 total - Exercise/Conversion
Stock Appreciation Right
2018-02-16−6,875→ 0 totalExercise: $37.18Exp: 2023-02-06→ Common Stock (6,875 underlying)
Footnotes (2)
- [F1]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- [F2]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.